Service Corporation International
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCI research report →
Range $85 – $105
Price Chart
About the company
Service Corporation International (SCI) is a leading provider of comprehensive end-of-life products and services across the United States and Canada. The company structures its extensive operations into two primary divisions: Funeral Services and Cemetery Operations. SCI's physical footprint encompasses a vast network of funeral homes, cemeteries, and crematories, including numerous integrated locations that offer both funeral and cemetery services.
- CEO
- Thomas Luke Ryan
- IPO
- 1980
- Employees
- 25,000
- HQ
- Houston, TX, US
Get TickerSpark's AI analysis on SCI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $9.40B
- P/E
- 14.65
- Fwd P/E
- 17.28
- PEG
- 0.57
- P/S
- 2.13
- P/B
- 5.99
- EV/EBITDA
- 10.63
- Div Yield
- 2.02%
- Gross Margin
- 25.89%
- Op Margin
- 22.75%
- Net Margin
- 14.76%
- ROE
- 41.18%
- ROIC
- 4.77%
Latest fiscal year · YoY change
- Revenue
- $4.31B+2.9%
- Gross Profit
- $1.14B+4.5%
- Op Income
- $973.92M
- Net Income
- $542.61M+4.6%
- EPS
- $3.83+7.3%
- OCF Growth
- -0.2%
- FCF Growth
- -0.3%
- 52W High
- $90.99
- 52W Low
- $68.41
- 50D MA
- $77.77
- 200D MA
- $79.48
- Beta
- 0.78
- RSI (14)
- 35
- Avg Volume
- 1.28M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
SCI delivered adjusted EPS growth and strong preneed sales in the third quarter, but weaker funeral volumes and higher costs pushed results below internal expectations and led to lower full-year EPS guidance.· October 29, 2026
- Adjusted EPS was $0.97, up more than 11% from $0.87 a year ago.
- Comparable preneed cemetery sales rose 5% and preneed funeral sales rose 6% in the quarter.
- Management cut 2026 normalized EPS midpoint to about $3.99 from the original $4.20 midpoint, citing softer funeral volumes and higher costs.
- Adjusted operating cash flow increased to $297 million, and full-year adjusted operating cash flow guidance was reaffirmed at $1.05 billion to $1.11 billion.
- The company returned just over $100 million to shareholders in the quarter and ended with about $1.7 billion of liquidity.
Third-quarter adjusted EPS was $0.97 versus $0.87 last year. Comparable funeral revenue increased by $19 million, or just over 3%, and comparable cemetery revenue increased by $19 million, or about 4%. Comparable core funeral revenue rose $11 million, or about 2.3%, while comparable core funeral volume declined 0.5%; comparable preneed cemetery sales production grew $17 million, or 5%, and preneed funeral sales production grew $19 million, or about 6%. Adjusted operating cash flow was $297 million, up $29 million, and total liquidity ended at about $1.7 billion. For Q4, SCI guided normalized EPS of $1.10 to $1.20. For full-year 2026, management now expects normalized EPS at the midpoint to be about $3.99, adjusted operating cash flow of $1.05 billion to $1.11 billion, maintenance CapEx of about $335 million, and adjusted free cash flow of about $750 million.
Tom Ryan said the quarter showed strong underlying sales momentum, especially in preneed funeral and cemetery, but results were held back by weaker-than-expected funeral volumes, lower general agency commission rates, higher fixed costs, and higher selling compensation. He framed 2026 as a year where execution was solid but timing and cost pressures hurt earnings, while emphasizing that the company is growing its $18 billion backlog and expects those sales to benefit future periods. His tone was candid and cautious on the year, but more constructive on 2027, when he expects preneed strength, flat to slightly higher funeral volumes, and better cost and pricing actions.
Eric Tanzberger highlighted adjusted operating cash flow of $297 million, up $29 million and 11% year over year, driven by higher operating income and a $30 million working-capital source, partly offset by more than $15 million of higher cash taxes. He said SCI invested $137 million in capital during the quarter, including $80 million of maintenance capital, $24 million of growth capital in real estate, and $34 million of acquisitions, and returned just over $100 million to shareholders through $53 million of buybacks and $49 million of dividends. He also noted about $31 million of corporate G&A, down $7 million to $8 million sequentially, and reiterated full-year cash flow, tax, liquidity, and leverage targets, including $1.7 billion of liquidity and net debt-to-EBITDA of about 3.7x.
Analysts focused on whether higher healthcare, advertising, fuel, and selling-cost pressures were temporary or would persist into 2027. Management said healthcare is likely persistent, while some promotional and rollout-related spending should normalize over time, and it expects to adjust pricing and manage costs more tightly next year. Questions also centered on the lower revenue-recognition rate in cemetery sales, with management saying the fourth quarter should seasonally improve but that a mix shift toward deferred merchandise, services, and undeveloped property is still weighing on timing. Analysts pressed on funeral volume weakness and acquisitions; management said market share appears intact, volumes mainly reflect a softer death-rate backdrop, and it will keep a patient acquisition approach focused on high-return opportunities rather than forcing deals.
SCI is still showing solid preneed demand, with comparable preneed cemetery sales up 5% and preneed funeral sales up 6% in the quarter, plus management calling 2026 sales growth mid-to-high single digits. Cash generation remains strong, adjusted free cash flow is guided to about $750 million, and the balance sheet has about $1.7 billion of liquidity. Management also sounded optimistic about 2027, citing improving demographics, backlog growth, and expected benefits as sales compensation changes anniversary and costs are better managed.
Earnings are under pressure from weaker-than-expected funeral volumes, lower general agency commission rates, higher fixed costs, and a higher selling-compensation burden, and management reduced the 2026 EPS midpoint to about $3.99. Funeral volumes were down enough that management now expects full-year volume to be about 200 basis points below initial assumptions, and it sees October trending below expectations as well. Cemetery revenue recognition is also being delayed by sales mix, which creates a timing mismatch between selling costs and recognized revenue, while healthcare and fuel costs may continue to weigh on margins.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.9%
- Shares Outstanding
- 135.91M
- Float Shares
- 133.11M
of shares held by institutions
572 13F filers
Buy/sell ratio 0.44. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for SCI, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| April McClain DelaneyHouse · MD06 | Sell | Aug 4, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Aug 3, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Aug 25, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Jul 8, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Jul 17, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Jul 20, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Jul 27, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Jul 30, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | Jul 2, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | May 7, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | May 18, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | May 15, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | May 8, 26 | Filing → |
| April McClain DelaneyHouse · MD06 | Sell | May 14, 26 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 14.06M | ▼ 514.09K |
| Vanguard Group Inc | 13.42M | ▼ 170.23K |
| Fmr LLC | 8.22M | ▲ 84.28K |
| Vanguard Portfolio Management LLC | 6.85M | ▼ 97.64K |
| Vanguard Capital Management LLC | 5.89M | ▼ 104.24K |
| T. Rowe Price Investment Management, Inc. | 5.51M | ▼ 1.13M |
| Fil Ltd | 4.79M | ▲ 505.38K |
| Raymond James Financial Inc | 4.51M | ▲ 330.37K |
| Baillie Gifford & Co | 4.42M | ▼ 1.13M |
| State Street Corp | 4.40M | ▲ 3.48K |
| Invesco Ltd. | 4.03M | ▼ 90.65K |
| Swedbank Ab | 4.03M | ▼ 97.89K |
Held by 548 ETFs
Biggest fund positions in SCI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 25, 26 | LUND VICTOR L | other | 193,900 |
| Jul 31, 26 | RYAN THOMAS L | other | 235,893 |
| Jul 31, 26 | RYAN THOMAS L | other | 17,498 |
| Jul 31, 26 | RYAN THOMAS L | sell | 17,498 |
| Jul 31, 26 | RYAN THOMAS L | sell | 235,893 |
| Jul 31, 26 | RYAN THOMAS L | other | 235,893 |
| Jul 31, 26 | RYAN THOMAS L | other | 17,498 |
| Aug 3, 26 | TANZBERGER ERIC D | other | 54,800 |
| Aug 3, 26 | TANZBERGER ERIC D | sell | 54,800 |
| Aug 3, 26 | TANZBERGER ERIC D | other | 54,600 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SCI coverage
Recent articles, reports, and earnings notes.
No research on SCI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCI report →CEL-SCI's Multikine® Receives Saudi FDA NADR Designation, Accelerating Potential Commercial Launch
businesswire.com · Nov 20
Service Corporation International (SCI) Presents at 2026 Stephens Annual Investment Conference | NASH2026 Transcript
seekingalpha.com · Nov 18
Service Corporation International: A Great Business At Just An Okay Price That's Worth Buying
seekingalpha.com · Nov 17
Service Corporation International (SCI) Presents at 2026 UBS Global Healthcare Conference Transcript
seekingalpha.com · Nov 10
CEL-SCI's Dr. Eyal Talor Receives Second International Keynote Invitation on Multikine Head and Neck Cancer Research
businesswire.com · Nov 10
SERVICE CORPORATION INTERNATIONAL DECLARES QUARTERLY CASH DIVIDEND
prnewswire.com · Nov 4
SCI Investors Have Opportunity to Join Service Corporation International Fraud Investigation with SBS Law
businesswire.com · Nov 3
SCI Stock Slips Post Q3 Earnings Despite Revenue Growth, Margin Down
zacks.com · Nov 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.